| Literature DB >> 34937912 |
Zhenmei Xu1, Tatsuya Ikuta2, Kouki Kawakami2, Ryoji Kise2, Yu Qian1, Ruixue Xia1, Ming-Xia Sun3, Anqi Zhang4, Changyou Guo4, Xue-Hui Cai3, Zhiwei Huang5, Asuka Inoue6, Yuanzheng He7.
Abstract
Sphingosine-1-phosphate receptor 1 (S1PR1) is a master regulator of lymphocyte egress from the lymph node and an established drug target for multiple sclerosis (MS). Mechanistically, therapeutic S1PR1 modulators activate the receptor yet induce sustained internalization through a potent association with β-arrestin. However, a structural basis of biased agonism remains elusive. Here, we report the cryo-electron microscopy (cryo-EM) structures of Gi-bound S1PR1 in complex with S1P, fingolimod-phosphate (FTY720-P) and siponimod (BAF312). In combination with functional assays and molecular dynamics (MD) studies, we reveal that the β-arrestin-biased ligands direct a distinct activation path in S1PR1 through the extensive interplay between the PIF and the NPxxY motifs. Specifically, the intermediate flipping of W2696.48 and the retained interaction between F2656.44 and N3077.49 are the key features of the β-arrestin bias. We further identify ligand-receptor interactions accounting for the S1PR subtype specificity of BAF312. These structural insights provide a rational basis for designing novel signaling-biased S1PR modulators.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34937912 DOI: 10.1038/s41589-021-00930-3
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 16.174